On Thursday, March 18th, RiboPro (a spin-off from Mecurna), and Pleco Therapeutics pitched and won a place in the semi-finals at the Global Investor Forum 2021. Pivot Park congratulates them on this achievement. For anyone that missed their pitch: join them on the 8th of April during the semi-finals.
BackRelated news
Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII)
We are pleased to share that Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII) by providing exciting data (in vitro and in vivo) on mCura1, Mercurna’s lead formulation for chronic kidney disease.
View articleRiboPro raises €1.2M to become leader in (m)RNA
RiboPro announced it has successfully closed a funding round of €1.2 million, led by Stichting Vlasroot
View article
A cup of coffee with … Sander van Asbeck
“It is our mission to develop the next generation of (nano)medicines; low in side-effects and high in efficacy."
View article